Cool-Bio
Wayne
About Cool-Bio
COOL~BIO is a biotechnology company focused on developing hypothermia-activated biologics. Therapeutic hypothermia (TH) is the process of cooling the body to prevent organ damage and is widely-used in cardiac surgery, ischemic stroke, cardiac arrest, neurosurgery and traumatic brain injury. Their lead molecule is an anti-platelet agent being developed for use during cardiopulmonary bypass.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Estimated revenue: $1K – $10K
- Funding stage: Seed
- Last round: Seed (May 2012)
- Website: cool-bio.com
Industries & Categories
Biotechnology, Medical
Canonical: https://fsome.com/organization/cool-bio-2677720 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.